| Activation of mTOR/IκB-α/NF-κB pathway contributes to LPS-induced hypotension and inflammation in rats M Temiz-Resitoglu, SP Kucukkavruk, DS Guden, P Cecen, AN Sari, ... European Journal of Pharmacology 802, 7-19, 2017 | 74 | 2017 |
| Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91phox to the protective effect of 5, 14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia … B Tunctan, B Korkmaz, AN Sari, M Kacan, D Unsal, MS Serin, ... Nitric Oxide 33, 18-41, 2013 | 71 | 2013 |
| Inhibition of NLRP3 inflammasome prevents LPS-induced inflammatory hyperalgesia in mice: contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS isoforms A Dolunay, SP Senol, M Temiz-Resitoglu, DS Guden, AN Sari, ... Inflammation 40, 366-386, 2017 | 65 | 2017 |
| 5, 14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: contribution of soluble epoxide hydrolase, CYP2C23, MEK1/ERK1/2 … B Tunctan, B Korkmaz, AN Sari, M Kacan, D Unsal, MS Serin, ... Prostaglandins & other lipid mediators 102, 31-41, 2013 | 34 | 2013 |
| Effects of 5, 14-HEDGE, a 20-HETE mimetic, on lipopolysaccharide-induced changes in MyD88/TAK1/IKKβ/IκB-α/NF-κB pathway and circulating miR-150, miR-223, and miR-297 levels in … AN Sari, B Korkmaz, MS Serin, M Kacan, D Unsal, CK Buharalioglu, ... Inflammation research 63, 741-756, 2014 | 32 | 2014 |
| Protection by mTOR inhibition on zymosan-induced systemic inflammatory response and oxidative/nitrosative stress: contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB signalling … S Sahan-Firat, M Temiz-Resitoglu, DS Guden, SP Kucukkavruk, ... Inflammation 41, 276-298, 2018 | 31 | 2018 |
| Contribution of RhoA/Rho-kinase/MEK1/ERK1/2/iNOS pathway to ischemia/reperfusion-induced oxidative/nitrosative stress and inflammation leading to distant and target organ … AN Sari, M Kacan, D Unsal, SS Firat, CK Buharalioglu, O Vezir, ... European journal of pharmacology 723, 234-245, 2014 | 27 | 2014 |
| NS-398 reverses hypotension in endotoxemic rats: contribution of eicosanoids, NO, and peroxynitrite B Tunctan, AN Sari, M Kacan, D Unsal, CK Buharalioglu, S Sahan-Firat, ... Prostaglandins & other lipid mediators 104, 93-108, 2013 | 22 | 2013 |
| Bexarotene, a selective RXRα agonist, reverses hypotension associated with inflammation and tissue injury in a rat model of septic shock B Tunctan, SP Kucukkavruk, M Temiz-Resitoglu, DS Guden, AN Sari, ... Inflammation 41, 337-355, 2018 | 19 | 2018 |
| Piroxicam Reverses Endotoxin‐Induced Hypotension in Rats: Contribution of Vasoactive Eicosanoids and Nitric Oxide CK Buharalioglu, B Korkmaz, T Cuez, S Sahan‐Firat, AN Sari, KU Malik, ... Basic & clinical pharmacology & toxicology 109 (3), 186-194, 2011 | 18 | 2011 |
| Contribution of PPARα/β/γ, AP-1, importin-α3, and RXRα to the protective effect of 5, 14-HEDGE, a 20-HETE mimetic, against hypotension, tachycardia, and inflammation in a rat … SP Senol, M Temiz, DS Guden, P Cecen, AN Sari, S Sahan-Firat, ... Inflammation Research 65, 367-387, 2016 | 17 | 2016 |
| The role of Syk/IĸB‐α/NF‐ĸB pathway activation in the reversal effect of BAY 61‐3606, a selective Syk inhibitor, on hypotension and inflammation in a rat model of zymosan … D Unsal, M Kacan, M Temiz‐Resitoglu, DS Guden, B Korkmaz, AN Sari, ... Clinical and Experimental Pharmacology and Physiology 45 (2), 155-165, 2018 | 15 | 2018 |
| NF‐κB activation mediates LPS‐or zymosan‐induced hypotension and inflammation reversed by BAY 61‐3606, a selective Syk inhibitor, in rat models of septic and non‐septic shock S Sahan‐Firat, M Temiz‐Resitoglu, DS Guden, SP Senol, AN Sari, M Cil, ... Clinical and Experimental Pharmacology and Physiology 46 (2), 173-182, 2019 | 13 | 2019 |
| Suppression of TLR4/MyD88/TAK1/NF-κB/COX-2 signaling pathway in the central nervous system by bexarotene, a selective RXR agonist, prevents hyperalgesia in the … SP Senol, M Temiz-Resitoglu, DS Guden, AN Sari, S Sahan-Firat, ... Neurochemical Research 46, 624-637, 2021 | 8 | 2021 |
| Inhibition of NLRP3 inflammasome contributes to protective effect of 5, 14-HEDGE against lipopolysaccharide-induced septic shock B Tunctan, SP Kucukkavruk, M Temiz-Resitoglu, DS Guden, AN Sari, ... International Journal of Pharmacology 13 (6), 654-666, 2017 | 7 | 2017 |
| Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl‐3‐(1‐propionylpiperidin‐4‐yl) urea prevents hyperalgesia through regulating NLRC4 inflammasome‐related pro … A Cagli, SP Senol, M Temiz‐Resitoglu, DS Guden, AN Sari, ... Drug Development Research 82 (6), 815-825, 2021 | 5 | 2021 |
| Yangına dirençli orman projelerine (YARDOP) ait uygulamaların değerlendirilmesi (Antalya örneği). II C Güngöroğlu, CO Güney, A Sarı Ulusal Akdeniz Orman ve Çevre Sempozyumu “Akdeniz Ormanlarının Geleceği …, 2014 | 5 | 2014 |
| Contribution of iNOS, COX-2 and CYP4A1 to the protective effect of a synthetic analog of 20-HETE, 5, 14-HEDGE, against endotoxin-induced hypotension and mortality in … B Tunctan, B Korkmaz, T Cuez, AN Sarı, M Kacan, D Gilik, ... Inflamm Res 60, S55, 2011 | 5 | 2011 |
| Activation of GPR75 signaling pathway contributes to the effect of a 20-HETE mimetic, 5, 14-HEDGE, to prevent hypotensive and tachycardic responses to lipopolysaccharide in a … B Tunctan, SP Senol, M Temiz-Resitoglu, DE Yilmaz, DS Guden, ... Journal of Cardiovascular Pharmacology 80 (2), 276-293, 2022 | 4 | 2022 |
| Rho kinaz ve kardiyovasküler hastalıklar AN Sarı, SŞ Fırat, B Tunçtan Mersin Üniversitesi Sağlık Bilimleri Dergisi 3 (2), 2011 | 4 | 2011 |
